Literature DB >> 18097295

Efficacy of endoscopic ultrasound in characterizing mass lesions in chronic pancreatitis.

Jayaprakash Sreenarasimhaiah1.   

Abstract

BACKGROUND AND GOALS: The aim of this study is to determine the influence of endoscopic ultrasound (EUS) in the detection of chronic pancreatitis and identification of pancreatic masses suspected by other radiographic imaging modalities in such a clinical background.
METHODS: Retrospective analysis was performed on 105 consecutive pancreatic EUS examinations in an 18-month period at a single tertiary care referral center. Analysis included 75 patients with a suspected pancreatic mass by computerized axial tomography, magnetic resonance imaging, ultrasound, or endoscopic retrograde cholangiopancreotography. All patients underwent EUS examination and if a mass was visualized, fine-needle aspiration biopsy was performed. Patients underwent either surgical exploration or clinical and radiographic follow-up for 6 months to confirm EUS findings.
RESULTS: Chronic pancreatitis was suspected in 53 individuals by clinical or radiographic methods. Using standard EUS parenchymal and ductal criteria, chronic pancreatitis was confirmed in 41 (77%) of patients. In 33 patients with chronic pancreatitis detected by EUS, initial referral was for pancreatic mass. Twenty-eight (85%) patients had an actual mass and the remainder were false-positive clinical findings. Thirty-two percent of pancreatic masses in chronic pancreatitis were found to be malignant adenocarcinoma and the rest were inflammatory in nature. Subset analysis showed EUS-fine-needle aspiration of solid lesions to have a sensitivity and specificity of 87.9% and 100%, respectively. Detection of cystic lesions had a sensitivity and specificity of 88.5% and 100%, respectively.
CONCLUSIONS: EUS is superior to other radiographic modalities in the determination of chronic pancreatitis and detection of mass lesions.

Entities:  

Mesh:

Year:  2008        PMID: 18097295     DOI: 10.1097/MCG.0b013e31802c4bfb

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

1.  The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma.

Authors:  Sundeep Singh; Shou-jiang Tang; Jayaprakash Sreenarasimhaiah; Luis F Lara; Ali Siddiqui
Journal:  Dig Dis Sci       Date:  2011-04-23       Impact factor: 3.199

2.  Spare the steroids, miss the diagnosis?

Authors:  John Baillie
Journal:  Curr Gastroenterol Rep       Date:  2009-04

Review 3.  Head mass in chronic pancreatitis: Inflammatory or malignant.

Authors:  Amit K Dutta; Ashok Chacko
Journal:  World J Gastrointest Endosc       Date:  2015-03-16

4.  Staining for p53 and Ki-67 increases the sensitivity of EUS-FNA to detect pancreatic malignancy.

Authors:  Alexander W Jahng; Sonya Reicher; David Chung; Donna Varela; Rahul Chhablani; Anil Dev; Binh Pham; Jose Nieto; Rose J Venegas; Samuel W French; Bruce E Stabile; Viktor E Eysselein
Journal:  World J Gastrointest Endosc       Date:  2010-11-16

Review 5.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.